SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-054482
Filing Date
2021-04-23
Accepted
2021-04-23 16:31:06
Documents
12
Period of Report
2021-06-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2113795d1_def14a.htm DEF 14A 399987
2 GRAPHIC image_001.jpg GRAPHIC 3824
3 GRAPHIC image_002.jpg GRAPHIC 2101
4 GRAPHIC image_003.jpg GRAPHIC 2657
5 GRAPHIC image_004.jpg GRAPHIC 3428
6 GRAPHIC image_005.jpg GRAPHIC 877
7 GRAPHIC image_006.jpg GRAPHIC 924
8 GRAPHIC image_007.jpg GRAPHIC 2601
9 GRAPHIC image_008.jpg GRAPHIC 659401
10 GRAPHIC image_009.jpg GRAPHIC 484492
11 GRAPHIC image_010.jpg GRAPHIC 494704
12 GRAPHIC image_011.jpg GRAPHIC 377534
  Complete submission text file 0001104659-21-054482.txt   3202460
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33958 | Film No.: 21850229
SIC: 2834 Pharmaceutical Preparations